Charles Schwab Investment Management Inc Opti Nose, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Opti Nose, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 36,174 shares of OPTN stock, worth $17,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,174

Previous 36,174 -0.0%

Holding current value

$17,363

Previous $37,000 35.14%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.82 - $1.44 $136,640 - $239,954	-166,635 Reduced 82.16%	36,174 $37,000
Q2 2023 Aug 09, 2023	BUY	$1.11 - $2.05 $184,964 - $341,601	166,635 Added 460.65%	202,809 $249,000
Q1 2023 May 11, 2023	BUY	$1.63 - $2.02 $31,056 - $38,487	19,053 Added 111.28%	36,174 $69,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $46,407 - $54,255	-13,530 Reduced 44.14%	17,121 $63,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.82 $11,839 - $25,697	-6,727 Reduced 18.0%	30,651 $113,000
Q1 2022 May 13, 2022	BUY	$1.77 - $2.93 $66,159 - $109,517	37,378 New	37,378 $93,000
Q3 2021 Nov 16, 2021	SELL	$2.35 - $3.16 $385,975 - $519,014	-164,245 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $243,878 - $320,980	-83,807 Reduced 33.79%	164,245 $511,000
Q1 2021 May 17, 2021	BUY	$3.47 - $4.75 $28,512 - $39,030	8,217 Added 3.43%	248,052 $916,000
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $52,528 - $81,746	16,415 Added 7.35%	239,835 $993,000
Q3 2020 Nov 13, 2020	BUY	$3.69 - $7.09 $161,260 - $309,847	43,702 Added 24.32%	223,420 $872,000
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $63,527 - $132,022	17,745 Added 10.96%	179,718 $1.34 Million
Q1 2020 May 15, 2020	BUY	$3.49 - $9.2 $23,198 - $61,152	6,647 Added 4.28%	161,973 $728,000
Q4 2019 Feb 07, 2020	BUY	$6.27 - $11.41 $145,206 - $264,244	23,159 Added 17.52%	155,326 $1.43 Million
Q3 2019 Nov 08, 2019	BUY	$4.75 - $8.38 $152,603 - $269,224	32,127 Added 32.11%	132,167 $926,000
Q2 2019 Aug 09, 2019	BUY	$6.4 - $10.94 $105,324 - $180,039	16,457 Added 19.69%	100,040 $709,000
Q1 2019 May 14, 2019	SELL	$6.1 - $10.3 $14,487 - $24,462	-2,375 Reduced 2.76%	83,583 $861,000
Q4 2018 Feb 14, 2019	BUY	$5.84 - $11.92 $36,429 - $74,356	6,238 Added 7.82%	85,958 $533,000
Q3 2018 Nov 13, 2018	BUY	$12.43 - $29.76 $113,883 - $272,661	9,162 Added 12.99%	79,720 $991,000
Q2 2018 Aug 08, 2018	BUY	$18.75 - $28.46 $879,093 - $1.33 Million	46,885 Added 198.05%	70,558 $1.98 Million
Q1 2018 May 07, 2018	BUY	$15.91 - $20.82 $13,030 - $17,051	819 Added 3.58%	23,673 $474,000
Q4 2017 Jan 17, 2018	BUY	$15.2 - $20.76 $347,380 - $474,449	22,854	22,854 $432,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Opti Nose, Inc. Transaction History